Journals / International Journal of PharmATA / 2022 / Cilt: 2 - Sayı: 1

Covid-19 and Antiviral Drugs Used In Its Treatment

Pages
25–29
Publication Date
2022-01-25
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

These methods are; The preparation of plasma samples includes protein precipitation (PP), solid phase extraction (SPE), liquid-liquid extraction (LLE), or a combination of two or more of these.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The new coronavirus, the seventh family member of β coronaviruses, entered our lives as 2019-nCoV.
📊
Key Findings & Data:The first outbreak was seen in December 2019 in Wuhan, China.
💡
Conclusion & Impact:These methods are; The preparation of plasma samples includes protein precipitation (PP), solid phase extraction (SPE), liquid-liquid extraction (LLE), or a combination of two or more of these.
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Antiviral drugs · extraction · Sars-Cov-2

Abstract

The new coronavirus, the seventh family member of β coronaviruses, entered our lives as 2019-nCoV. The first outbreak was seen in December 2019 in Wuhan, China. It has been reported as a zoonotic disease. 2019-nCoV; causes fatal diseases affecting the lungs, heart, liver and the whole body. 2019-nCoV interacts with ACE-2 and infects epithelial cells, initiating endothelial activation, localized inflammation, tissue damage, and dysregulated cytokine release. Antiviral drugs that selectively bind to viral proteases block the proteolytic cleavage of protein precursors necessary to produce infectious, thereby preventing viral replication. Newly designed antiviral drugs act not on viral entry into host cells but instead by blocking one or more steps of virus replication within the cell. Appropriate analytical methods are required to monitor the precise amount, distribution, metabolism, adsorption and elimination of these drugsand their metabolites in biofluids and tissues. These methods are; The preparation of plasma samples includes protein precipitation (PP), solid phase extraction (SPE), liquid-liquid extraction (LLE), or a combination of two or more of these.

🔖

Cite This Article

YÜKSEL, B., KADIOĞLU, Y. (2022). Covid-19 and Antiviral Drugs Used In Its Treatment. International Journal of PharmATA, Cilt: 2 - Sayı: 1, 25–29. https://ajindex.com/articles/877221

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Malik YA, Properties of Coronavirus and SARS-CoV-2. Malays J Pathol. 2020; 42; 3-11
  2. Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, et al, SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients. N Engl J Med. 2020; 382; 1177-1179
  3. Diriba K, Awulachew E, Getu E, The effect of coronavirus infection (SARS-CoV2, MERS-CoV, and SARS-CoV) during pregnancy and the possibility of vertical maternal-fetal transmission: a systematic review and meta-analysis. Eur J Med Res. 2020; 25; 39
  4. Ahn DG, Shin HJ, Kim MH, Lee S, Kim HS, Myoung J, et al, Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19). J Microbiol Biotechnol. 2020; 30; 313-324
  5. Shi Y, Wang G, Cai XP, Deng JW, Zheng L, Zhu HH, et al, An overview of COVID-19. J Zhejiang Univ Sci B. 2020; 21; 343-360
  6. Higgins V, Sohaei D, Diamandis EP, Prassas I, COVID-19: from an acute to chronic disease? Potential long-term health consequences. Crit Rev Clin Lab Sci. 2021; 58; 297-310
  7. Majumder J, Minko T, Recent Developments on Therapeutic and Diagnostic Approaches for COVID-19. Aaps j. 2021; 23; 14
  8. Samudrala PK, Kumar P, Choudhary K, Thakur N, Wadekar GS, Dayaramani R, et al, Virology, pathogenesis, diagnosis and in-line treatment of COVID-19. Eur J Pharmacol. 2020; 883; 173375
  9. Boretti A, Favipiravir use for SARS CoV-2 infection. Pharmacol Rep. 2020; 72; 1542-1552
  10. Joshi S, Parkar J, Ansari A, Vora A, Talwar D, Tiwaskar M, et al, Role of favipiravir in the treatment of COVID-19. Int J Infect Dis. 2021; 102; 501-508
  11. Şimşek SY, Ünal S. Antiviral treatment of COVID-19. Turk J Med Sci. 2020; 50; 611-619
  12. Lin HXJ, Cho S, Meyyur Aravamudan V, Sanda HY, Palraj R, Molton JS, et al, Remdesivir in Coronavirus Disease 2019 (COVID-19) treatment: a review of evidence. Infection. 2021; 49; 401-410
  13. Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB, Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review. Jama. 2020; 323; 1824-1836
  14. Wang D, Li Z, Liu Y, An overview of the safety, clinical application and antiviral research of the COVID-19 therapeutics. J Infect Public Health. 2020; 13; 1405-1414
  15. Bartoli A, Gabrielli F, Alicandro T, Nascimbeni F, Andreone P, COVID-19 treatment options: a difficult journey between failed attempts and experimental drugs. Intern Emerg Med. 2021; 16; 281-308
  16. Agarwal S, Agarwal SK, Lopinavir-Ritonavir in SARS-CoV-2 Infection and Drug-Drug Interactions